Cancer

Blincyto approved for rare leukemia

(HealthDay)—Blincyto (blinatumomab) has been approved by the U.S. Food and Drug Administration to treat Philadelphia chromosome-negative precursor B-cell acute lymphoblastic leukemia, a rare cancer of the bone marrow.

Dec 03, 2014
popularity not rated yet | comments 0

The links between obesity and cancer

As the global cancer community convenes this week in Melbourne for the UICC World Cancer Congress, thousands of experts and cancer survivors are arriving into Australia to discuss, present and move this ...

Dec 03, 2014
popularity 5 / 5 (3) | comments 0

Lung cancer risk model refines decisions to screen

A new method for determining lung cancer risk could more efficiently identify individuals for annual screening and catch more cancers early, according to a study published in this week's PLOS Medicine. The study, conducted by Mar ...

Dec 02, 2014
popularity not rated yet | comments 0

New substance overcomes treatment-restistance in leukemia

Haematologists from Goethe University Frankfurt, working with a Russian pharmaceutical company, have developed a new active substance that effectively combats the most aggressive forms of Philadelphia chromosome-positive ...

Dec 01, 2014
popularity 5 / 5 (2) | comments 0

Gene test aids cancer profile

The first round of chemotherapy did little to suppress Ron Bose's leukemia. The second round, with 10 times the dose, knocked the proliferating blast cells down, but only by half.

Nov 27, 2014
popularity 5 / 5 (1) | comments 0

How a common antacid could lead to cheaper anti-cancer drugs

A popular indigestion medication can increase survival in colorectal cancer, according to research published in ecancermedicalscience. But in fact, scientists have studied this for years - and a group of cancer advocates want t ...

Nov 26, 2014
popularity 4.3 / 5 (7) | comments 1